Copyright Reports & Markets. All rights reserved.

Global Anti-Neoplastic Therapy Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Anti-Neoplastic Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Chemotherapeutic Agents
    • 1.2.3 Immunotherapeutic Agents
    • 1.2.4 Personalized Medicine
  • 1.3 Market by Application
    • 1.3.1 Global Anti-Neoplastic Therapy Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Cancer Rehabilitation Centers
    • 1.3.5 Ambulatory Surgical Centers
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Anti-Neoplastic Therapy Market Perspective (2016-2027)
  • 2.2 Anti-Neoplastic Therapy Growth Trends by Regions
    • 2.2.1 Anti-Neoplastic Therapy Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Anti-Neoplastic Therapy Historic Market Share by Regions (2016-2021)
    • 2.2.3 Anti-Neoplastic Therapy Forecasted Market Size by Regions (2022-2027)
  • 2.3 Anti-Neoplastic Therapy Industry Dynamic
    • 2.3.1 Anti-Neoplastic Therapy Market Trends
    • 2.3.2 Anti-Neoplastic Therapy Market Drivers
    • 2.3.3 Anti-Neoplastic Therapy Market Challenges
    • 2.3.4 Anti-Neoplastic Therapy Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Anti-Neoplastic Therapy Players by Revenue
    • 3.1.1 Global Top Anti-Neoplastic Therapy Players by Revenue (2016-2021)
    • 3.1.2 Global Anti-Neoplastic Therapy Revenue Market Share by Players (2016-2021)
  • 3.2 Global Anti-Neoplastic Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Anti-Neoplastic Therapy Revenue
  • 3.4 Global Anti-Neoplastic Therapy Market Concentration Ratio
    • 3.4.1 Global Anti-Neoplastic Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Anti-Neoplastic Therapy Revenue in 2020
  • 3.5 Anti-Neoplastic Therapy Key Players Head office and Area Served
  • 3.6 Key Players Anti-Neoplastic Therapy Product Solution and Service
  • 3.7 Date of Enter into Anti-Neoplastic Therapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-Neoplastic Therapy Breakdown Data by Type

  • 4.1 Global Anti-Neoplastic Therapy Historic Market Size by Type (2016-2021)
  • 4.2 Global Anti-Neoplastic Therapy Forecasted Market Size by Type (2022-2027)

5 Anti-Neoplastic Therapy Breakdown Data by Application

  • 5.1 Global Anti-Neoplastic Therapy Historic Market Size by Application (2016-2021)
  • 5.2 Global Anti-Neoplastic Therapy Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Anti-Neoplastic Therapy Market Size (2016-2027)
  • 6.2 North America Anti-Neoplastic Therapy Market Size by Type
    • 6.2.1 North America Anti-Neoplastic Therapy Market Size by Type (2016-2021)
    • 6.2.2 North America Anti-Neoplastic Therapy Market Size by Type (2022-2027)
    • 6.2.3 North America Anti-Neoplastic Therapy Market Size by Type (2016-2027)
  • 6.3 North America Anti-Neoplastic Therapy Market Size by Application
    • 6.3.1 North America Anti-Neoplastic Therapy Market Size by Application (2016-2021)
    • 6.3.2 North America Anti-Neoplastic Therapy Market Size by Application (2022-2027)
    • 6.3.3 North America Anti-Neoplastic Therapy Market Size by Application (2016-2027)
  • 6.4 North America Anti-Neoplastic Therapy Market Size by Country
    • 6.4.1 North America Anti-Neoplastic Therapy Market Size by Country (2016-2021)
    • 6.4.2 North America Anti-Neoplastic Therapy Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Anti-Neoplastic Therapy Market Size (2016-2027)
  • 7.2 Europe Anti-Neoplastic Therapy Market Size by Type
    • 7.2.1 Europe Anti-Neoplastic Therapy Market Size by Type (2016-2021)
    • 7.2.2 Europe Anti-Neoplastic Therapy Market Size by Type (2022-2027)
    • 7.2.3 Europe Anti-Neoplastic Therapy Market Size by Type (2016-2027)
  • 7.3 Europe Anti-Neoplastic Therapy Market Size by Application
    • 7.3.1 Europe Anti-Neoplastic Therapy Market Size by Application (2016-2021)
    • 7.3.2 Europe Anti-Neoplastic Therapy Market Size by Application (2022-2027)
    • 7.3.3 Europe Anti-Neoplastic Therapy Market Size by Application (2016-2027)
  • 7.4 Europe Anti-Neoplastic Therapy Market Size by Country
    • 7.4.1 Europe Anti-Neoplastic Therapy Market Size by Country (2016-2021)
    • 7.4.2 Europe Anti-Neoplastic Therapy Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Anti-Neoplastic Therapy Market Size (2016-2027)
  • 8.2 Asia-Pacific Anti-Neoplastic Therapy Market Size by Type
    • 8.2.1 Asia-Pacific Anti-Neoplastic Therapy Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Anti-Neoplastic Therapy Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Anti-Neoplastic Therapy Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Anti-Neoplastic Therapy Market Size by Application
    • 8.3.1 Asia-Pacific Anti-Neoplastic Therapy Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Anti-Neoplastic Therapy Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Anti-Neoplastic Therapy Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Anti-Neoplastic Therapy Market Size by Region
    • 8.4.1 Asia-Pacific Anti-Neoplastic Therapy Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Anti-Neoplastic Therapy Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Anti-Neoplastic Therapy Market Size (2016-2027)
  • 9.2 Latin America Anti-Neoplastic Therapy Market Size by Type
    • 9.2.1 Latin America Anti-Neoplastic Therapy Market Size by Type (2016-2021)
    • 9.2.2 Latin America Anti-Neoplastic Therapy Market Size by Type (2022-2027)
    • 9.2.3 Latin America Anti-Neoplastic Therapy Market Size by Type (2016-2027)
  • 9.3 Latin America Anti-Neoplastic Therapy Market Size by Application
    • 9.3.1 Latin America Anti-Neoplastic Therapy Market Size by Application (2016-2021)
    • 9.3.2 Latin America Anti-Neoplastic Therapy Market Size by Application (2022-2027)
    • 9.3.3 Latin America Anti-Neoplastic Therapy Market Size by Application (2016-2027)
  • 9.4 Latin America Anti-Neoplastic Therapy Market Size by Country
    • 9.4.1 Latin America Anti-Neoplastic Therapy Market Size by Country (2016-2021)
    • 9.4.2 Latin America Anti-Neoplastic Therapy Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Anti-Neoplastic Therapy Market Size (2016-2027)
  • 10.2 Middle East & Africa Anti-Neoplastic Therapy Market Size by Type
    • 10.2.1 Middle East & Africa Anti-Neoplastic Therapy Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Anti-Neoplastic Therapy Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Anti-Neoplastic Therapy Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Anti-Neoplastic Therapy Market Size by Application
    • 10.3.1 Middle East & Africa Anti-Neoplastic Therapy Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Anti-Neoplastic Therapy Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Anti-Neoplastic Therapy Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Anti-Neoplastic Therapy Market Size by Country
    • 10.4.1 Middle East & Africa Anti-Neoplastic Therapy Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Anti-Neoplastic Therapy Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Amgen Inc.
    • 11.1.1 Amgen Inc. Company Details
    • 11.1.2 Amgen Inc. Business Overview
    • 11.1.3 Amgen Inc. Anti-Neoplastic Therapy Introduction
    • 11.1.4 Amgen Inc. Revenue in Anti-Neoplastic Therapy Business (2016-2021)
    • 11.1.5 Amgen Inc. Recent Development
  • 11.2 AstraZeneca plc
    • 11.2.1 AstraZeneca plc Company Details
    • 11.2.2 AstraZeneca plc Business Overview
    • 11.2.3 AstraZeneca plc Anti-Neoplastic Therapy Introduction
    • 11.2.4 AstraZeneca plc Revenue in Anti-Neoplastic Therapy Business (2016-2021)
    • 11.2.5 AstraZeneca plc Recent Development
  • 11.3 Bayer AG
    • 11.3.1 Bayer AG Company Details
    • 11.3.2 Bayer AG Business Overview
    • 11.3.3 Bayer AG Anti-Neoplastic Therapy Introduction
    • 11.3.4 Bayer AG Revenue in Anti-Neoplastic Therapy Business (2016-2021)
    • 11.3.5 Bayer AG Recent Development
  • 11.4 Johnson & Johnson
    • 11.4.1 Johnson & Johnson Company Details
    • 11.4.2 Johnson & Johnson Business Overview
    • 11.4.3 Johnson & Johnson Anti-Neoplastic Therapy Introduction
    • 11.4.4 Johnson & Johnson Revenue in Anti-Neoplastic Therapy Business (2016-2021)
    • 11.4.5 Johnson & Johnson Recent Development
  • 11.5 Merck & Co., Inc.
    • 11.5.1 Merck & Co., Inc. Company Details
    • 11.5.2 Merck & Co., Inc. Business Overview
    • 11.5.3 Merck & Co., Inc. Anti-Neoplastic Therapy Introduction
    • 11.5.4 Merck & Co., Inc. Revenue in Anti-Neoplastic Therapy Business (2016-2021)
    • 11.5.5 Merck & Co., Inc. Recent Development
  • 11.6 Pfizer Inc.
    • 11.6.1 Pfizer Inc. Company Details
    • 11.6.2 Pfizer Inc. Business Overview
    • 11.6.3 Pfizer Inc. Anti-Neoplastic Therapy Introduction
    • 11.6.4 Pfizer Inc. Revenue in Anti-Neoplastic Therapy Business (2016-2021)
    • 11.6.5 Pfizer Inc. Recent Development
  • 11.7 F. Hoffmann-La Roche Ltd.
    • 11.7.1 F. Hoffmann-La Roche Ltd. Company Details
    • 11.7.2 F. Hoffmann-La Roche Ltd. Business Overview
    • 11.7.3 F. Hoffmann-La Roche Ltd. Anti-Neoplastic Therapy Introduction
    • 11.7.4 F. Hoffmann-La Roche Ltd. Revenue in Anti-Neoplastic Therapy Business (2016-2021)
    • 11.7.5 F. Hoffmann-La Roche Ltd. Recent Development
  • 11.8 Eli Lilly and Company
    • 11.8.1 Eli Lilly and Company Company Details
    • 11.8.2 Eli Lilly and Company Business Overview
    • 11.8.3 Eli Lilly and Company Anti-Neoplastic Therapy Introduction
    • 11.8.4 Eli Lilly and Company Revenue in Anti-Neoplastic Therapy Business (2016-2021)
    • 11.8.5 Eli Lilly and Company Recent Development
  • 11.9 Teva Pharmaceutical Industries Ltd.
    • 11.9.1 Teva Pharmaceutical Industries Ltd. Company Details
    • 11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
    • 11.9.3 Teva Pharmaceutical Industries Ltd. Anti-Neoplastic Therapy Introduction
    • 11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Anti-Neoplastic Therapy Business (2016-2021)
    • 11.9.5 Teva Pharmaceutical Industries Ltd. Recent Development
  • 11.10 Boehringer Ingelheim
    • 11.10.1 Boehringer Ingelheim Company Details
    • 11.10.2 Boehringer Ingelheim Business Overview
    • 11.10.3 Boehringer Ingelheim Anti-Neoplastic Therapy Introduction
    • 11.10.4 Boehringer Ingelheim Revenue in Anti-Neoplastic Therapy Business (2016-2021)
    • 11.10.5 Boehringer Ingelheim Recent Development
  • 11.11 Aspen Pharmacare Holdings Limited
    • 11.11.1 Aspen Pharmacare Holdings Limited Company Details
    • 11.11.2 Aspen Pharmacare Holdings Limited Business Overview
    • 11.11.3 Aspen Pharmacare Holdings Limited Anti-Neoplastic Therapy Introduction
    • 11.11.4 Aspen Pharmacare Holdings Limited Revenue in Anti-Neoplastic Therapy Business (2016-2021)
    • 11.11.5 Aspen Pharmacare Holdings Limited Recent Development
  • 11.12 AbbVie Inc.
    • 11.12.1 AbbVie Inc. Company Details
    • 11.12.2 AbbVie Inc. Business Overview
    • 11.12.3 AbbVie Inc. Anti-Neoplastic Therapy Introduction
    • 11.12.4 AbbVie Inc. Revenue in Anti-Neoplastic Therapy Business (2016-2021)
    • 11.12.5 AbbVie Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Anti-Neoplastic Therapy Scope and Market Size
    Anti-Neoplastic Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Neoplastic Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Chemotherapeutic Agents
    Immunotherapeutic Agents
    Personalized Medicine

    Segment by Application
    Hospitals
    Clinics
    Cancer Rehabilitation Centers
    Ambulatory Surgical Centers

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Amgen Inc.
    AstraZeneca plc
    Bayer AG
    Johnson & Johnson
    Merck & Co., Inc.
    Pfizer Inc.
    F. Hoffmann-La Roche Ltd.
    Eli Lilly and Company
    Teva Pharmaceutical Industries Ltd.
    Boehringer Ingelheim
    Aspen Pharmacare Holdings Limited
    AbbVie Inc.

    Buy now